Hatsuho Mamata1,2, Ritu R. Gill1,2,
Junichi Tokuda1,2, Robert F. Padera2,3, Robert E.
Lenkinski2,4, William G. Richards2,5, Tamara R.
Tilleman2,5, David J. Sugarbaker2,5, Hiroto Hatabu1,2
1Radiology, Brigham & Women's
Hospital, Boston, MA, United States; 2Harvard Medical School,
Boston, MA, United States; 3Pathology, Brigham & Women's
Hospital, Boston, MA, United States; 4Radiology, Beth Israel
Deaconess Medical Center, Boston, MA, United States; 5Thoracic
surgery, Brigham & Women's Hospital, Boston, MA, United States
Pharmacokinetic parameters correlate with growth type and age of malignant pleural mesothelioma (MPM), however, they do not have correlation with histological subtype. Ktrans, kep and time-intensity curve type may reflect inflammatory component of diffuse pleural thickening type MPM.